First Clinical Trial Using Stem Cell Therapy for Spinal Cord Injuries
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics , Stem Cells on January 28, 2009
The FDA has approved the world's first clinical trial on the use of stem cell therapy for patients with acute spinal cord injury. Geron Corporation will conduct a Phase I multi-center trial designed to establish the safety of GRNOPC1 in patients with "complete" American Spinal Injury Association (ASIA) grade A subacute thoracic spinal cord injuries.
The ultimate goal for the use of GRNOPC1 is to achieve restoration of spinal cord function by the injection of hESC-derived oligodendrocyte progenitor cells directly into the lesion site of the patient's injured spinal cord."
GRNOPC1, Geron's lead hESC-based therapeutic candidate, contains hESC-derived oligodendrocyte progenitor cells that have demonstrated remyelinating and nerve growth stimulating properties leading to restoration of function in animal models of acute spinal cord injury (Journal of Neuroscience, Vol. 25, 2005).
More information regarding the clinical trial here.
GRNOPC1, Geron's lead hESC-based therapeutic candidate, contains hESC-derived oligodendrocyte progenitor cells that have demonstrated remyelinating and nerve growth stimulating properties leading to restoration of function in animal models of acute spinal cord injury (Journal of Neuroscience, Vol. 25, 2005).
Tags: stem+cells stemcell spinal+cord clinical+trial section noscript+section
Vote for First Clinical Trial Using Stem Cell Therapy for Spinal Cord Injuries:
|
Rating: 9.33 out of 3 vote(s) cast.
|
Response from:
anita
(06/27/10 4:38am)
i had a Daughter she has spinal by fita by bith is that posible by stem therappy to do some changes in her
Response from:
Nayan
(03/02/11 10:21am)
Me and my colleagues authored one of India's most extensive reports on clinical trials. Drop me a mail if you are interested in a copy. My email is ntaluk@gmail.com.
Some of the topics we included are:
- Market Trends
- Growth Drivers
- Regulatory Bodies and Framework
- Major Players.
-Etc.
We interviewed over 200 individuals and firms to collect the data in what we believe is one of the most detailed study on the subject in India.
Nayan
ntaluk@gmail.com
Some of the topics we included are:
- Market Trends
- Growth Drivers
- Regulatory Bodies and Framework
- Major Players.
-Etc.
We interviewed over 200 individuals and firms to collect the data in what we believe is one of the most detailed study on the subject in India.
Nayan
ntaluk@gmail.com
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells